Antibody discovery platforms at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

7 antibody discovery platforms are at PepTalk 2027 — 7 presentations on the program and 2 with a booth in the exhibit hall. Most represented: Nabla Bio (2 on the program), A-Alpha Bio (1 on the program), Adimab (1 on the program). 3 of them have their own page in this guide. As of Oct 17, 2026.

All 166 organizations at PepTalk 2027 →

Showing 1–7 of 7 organizations

Organization	PepTalk 2027 Attendance
Nabla Bio Cambridge, MA
nabla.bio Discovery platforms Generative AI protein design company that designs antibodies and multispecifics against hard targets with pharmaceutical partners.	Talk Mon Jan 18 9:30am–10:00am De novo Design of Production-Ready Biologics at Scale across Pipelines SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 8:40am–9:10am Generative AI for de novo Design of Drug-Like Therapeutic Multispecifics Multispecifics Engineering & Design
A-Alpha Bio Seattle, WA	◆Premier Sponsor
aalphabio.com Discovery platformsPremier Sponsor Measures protein-protein binding at large scale in yeast and trains machine-learning models on the data to help partners engineer antibodies and multispecifics.	Booth Exhibiting at Booth 607 Talk Tue Jan 19 3:00pm–3:15pm Talk Title to be Announced Multispecifics Engineering & Design
Adimab Lebanon, NH
adimab.com Discovery platforms Discovers and optimizes antibodies and bispecifics for drug developers through partnerships built on its yeast display platform.	Talk Mon Jan 18 11:45am–12:15pm Discovery of Highly Selective pHLA-Targeting Therapeutics via Yeast-Based Libraries SYMPOSIUM: Display of Biologics
Menten AI
menten.ai Discovery platforms Partners with drug developers using a physics-based generative design platform for macrocyclic peptides.	Talk Wed Jan 20 11:40am–12:10pm Machine Learning Applied to Oral and Macrocyclic Peptide Design Peptide Discovery & Engineering
Sortera Bio Cambridge, UK
sortera.bio Discovery platforms Antibody engineering company whose Deep Screening method links binding measurements to sequences for millions of variants; works through partnerships, including with AstraZeneca.	Talk Mon Jan 18 9:00am–9:30am Deep Screening: An Ultra–High-Throughput Screening Platform for the Discovery of Conditional Antibodies SYMPOSIUM: Display of Biologics
Specifica Santa Fe, NM
specifica.bio Discovery platforms IQVIA-owned antibody discovery business selling Generation 3 and VHH display libraries, discovery and optimization campaigns, and transfers of its platform to clients' labs.	Chair Mon Jan 18 1:30pm–1:35pm Chairperson's Remarks SYMPOSIUM: Display of Biologics
Nona Biosciences	◆Corporate Sponsor
nonabio.com Discovery platformsCorporate Sponsor Harbour BioMed company offering Harbour Mice transgenic platforms and discovery services for fully human and heavy-chain-only antibodies and multispecifics.	Booth Exhibiting at Booth 501